| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) Department of Veterans Affairs |
| Information provided by: | National Institute on Drug Abuse (NIDA) |
| ClinicalTrials.gov Identifier: | NCT00000218 |
Purpose
The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
| Condition | Intervention | Phase |
|
Cocaine-Related Disorders Substance-Related Disorders |
Drug: Carbamazepine |
Phase IV |
| Drug Information available for: | Carbamazepine |
| Study Type: | Interventional |
| Study Design: | Treatment |
| Official Title: | Pharmacotherapy and Intensive Treatment |
Eligibility
| Ages Eligible for Study: | 18 Years to 60 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Please contact site for information.
Contacts and Locations More Information
| Study ID Numbers: | NIDA-06954-2, R18-06954-2 |
| First Received: | September 20, 1999 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00000218 |
| Health Authority: | United States: Federal Government |
|
|
|
|
